Effects of Imatinib on Rat Liver

Effects of Imatinib on Rat Liver

Aim:Imatinib is a protein tyrosine kinase inhibitor that’s used as an anticancer drug. In this study, evaluation the effects of different doses of imatinib on liver ultrastructurally and biochemically was aimed.Methods:200-250 g, 8-12 weeks old, 30 mature male Wistar rats were used. Rats were divide...

Full description

Bibliographic Details
Main Authors:	Yurdun Kuyucu, Leman Sencar
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2021-01-01
Series:	Haseki Tıp Bülteni
Subjects:	imatinib liver ultrastructure
Online Access:	http://www.hasekidergisi.com/archives/archive-detail/article-preview/effects-of-matinib-on-rat-liver/43959

Similar Items

Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST)
by: Seidel Christoph, et al.
Published: (2012-05-01)

Effects of Combined Admistration of Imatinib and Sorafenib in a Murine Model of Liver Fibrosis
by: Antonio Pesce, et al.
Published: (2020-09-01)

The Biological Effects of Imatinib on Male Fertility of Wistar Rats
by: Parichehre Yaghmaei, et al.
Published: (2009-11-01)

The effect of grape seed and green tea extracts on the pharmacokinetics of imatinib and its main metabolite, N-desmethyl imatinib, in rats
by: Ruba S. Darweesh, et al.
Published: (2020-11-01)

The teratogenic effects of imatinib mesylate on rat fetuses
by: M.M. El Gendy, et al.
Published: (2015-01-01)

Imatinib activity on Schistosoma mansoni
by: Naftale Katz, et al.
Published: (2013-11-01)

A histological study on the effect of imatinib on the rats' testis after early postnatal exposure
by: luma khalel, et al.
Published: (2021-01-01)

Effect of Imatinib on the Oogenesis and Pituitary -Ovary Hormonal Axis in Female Wistar Rat
by: Parichehreh Yaghmaei, et al.
Published: (2009-05-01)

Drug–drug interaction study of imatinib and voriconazole in vitro and in vivo
by: Lin QM, et al.
Published: (2019-04-01)

The effect of CO-Q10 on the testicular histological changes in rats induced by imatinib
by: Luma K. Al-Allaf, et al.
Published: (2021-01-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate
by: Vaneuza M. Funke, et al.
Published: (2008-04-01)

Effect of astaxanthin in imatinib mesylate-induced cardiotoxicity
by: İshak Suat Övey, et al.
Published: (2020-03-01)

Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01)

Association of the Trough, Peak/Trough Ratio of Imatinib, Pyridine–N-Oxide Imatinib and ABCG2 SNPs 34 G>A and SLCO1B3 334 T>G With Imatinib Response in Egyptian Chronic Myeloid Leukemia Patients
by: Mervat M. Omran, et al.
Published: (2020-08-01)

Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure
by: Aline Houessinon, et al.
Published: (2015-01-01)

Imatinib-induced extensive hyperpigmentation in a case of chronic myeloid leukemia
by: Pradeep Balasubramanian, et al.
Published: (2015-01-01)

Falla cardiaca asociada con el uso de imatinib mesilato: Reporte de un caso Heart failure associated to imatinib mesylate use: Case report
by: Clara Saldarriaga, et al.
Published: (2008-12-01)

Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
by: Min Kyu Kang, et al.
Published: (2019-05-01)

Nilotinib therapy after resistance and intolerance to imatinib in CML patient with trisomy of the chromosome 8
by: Antonella Russo Rossi
Published: (2015-10-01)

Imatinib resistance mutation analysis: experience from a tertiary oncology center
by: Mallekavu Suresh Babu, et al.
Published: (2015-01-01)

Ultrastructural and Biochemical Evaluation of the Effect of Endosulfan on Mice Liver
by: Yildiz Caglar, et al.
Published: (2013-04-01)

Imatinib and hypophosphatemia: Case report and review of literature
by: Erdem Şen, et al.
Published: (2017-07-01)

Efficacy and safety of generic imatinib after switching from original imatinib in patients treated for chronic myeloid leukemia in the United States
by: Iman Abou Dalle, et al.
Published: (2019-11-01)

Hematologic Relapse after 2 Years on a Non-Authorized Copy Version of Imatinib in a Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report
by: Zoubir Chouffai
Published: (2010-07-01)

Imatinib as adjuvant therapy for high risk GIST: a case report
by: Patrizia Lista, et al.
Published: (2015-10-01)

Imatinib Sets Pericyte Mosaic in the Retina
by: Tamás Kovács-Öller, et al.
Published: (2020-04-01)

Nilotinib therapy after resistance to imatinib
by: Raffaele Porrini, et al.
Published: (2015-10-01)

Imatinib resistance: diagnostic and therapeutic choices
by: Marianna De Muro, et al.
Published: (2015-10-01)

Sarcomas del estroma gastrointestinal tratados con Imatinib®: presentación de 2 casos Gastrointestinal stromal tumors treated with Imatinib®: report of 2 cases
by: Mayté Lima, et al.
Published: (2006-06-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Nilotinib after imatinib failure
by: Luca Pezzullo
Published: (2015-10-01)

Protective Effects of Imatinib and Ginkgo Biloba on Cisplatin-induced Ovarian Damage in Rats
by: Önder Sakin, et al.
Published: (2020-07-01)

Imatinib dose optimisation following the disease progression in a patient with metastatic GIST
by: Mariangela Parodi, et al.
Published: (2015-10-01)

Os desafios no tratamento da Leucemia mielóide crônica na era do mesilato de imatinibe Challenges in current chronic myeloid leukemia therapy of imatinib era
by: Cármino Antônio de Souza, et al.
Published: (2004-12-01)

Survival of Patients with CML on Imatinib Experience with 44 Iraqi Patients
by: Ali M. Jawad, et al.
Published: (2008-10-01)

Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation р.T632I
by: Kristina V. Orlova, et al.
Published: (2019-01-01)

HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells
by: Shu-Huey Chen, et al.
Published: (2019-05-01)

Reacciones adversas del imatinib como droga de segunda línea en pacientes con leucemia mieloide crónica Adverse reactions to imatinib as second-line drug in patients with chronic myeloid leukemia
by: Onel M. Ávila Cabrera, et al.
Published: (2010-12-01)

Cannot write session to /tmp/vufind_sessions/sess_0nhm0bc01ud7n4krarm2jt1qn4